Primary Site >> Biliary tract Cancer

Gene >> FLT1

Journal: Zhonghua Yi Xue Za Zhi. 2007 Dec 18;87(47):3329-34.
Title: [Effects of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotide on mRNA and expression of VEGF, flt-1, and kinase insert domain containing receptor and VEGF excretion in human gallbladder carcinoma cells].
Author: Fang, He-Qing|Li, Hai-Jun|Liu, Ying-Bin|Wang, Xu-An|Ma, Xiao-Ming|Kong, Ying|Chen, Yan|Chen, De-Qin|Weng, Wei-Hong|Zhang, Zhi-Ping|Devkota, K-R|Wang, Jian-Wei|Li, Jiang-Tao|Cao, Li-Ping|Peng, Shu-You
PMID: 18478945
Journal: Dig Liver Dis. 2009 Feb;41(2):156-63.
Title: Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor.
Author: Mancino, A|Mancino, M G|Glaser, S S|Alpini, G|Bolognese, A|Izzo, L|Francis, H|Onori, P|Franchitto, A|Ginanni-Corradini, S|Gaudio, E|Alvaro, D
PMID: 18395502
Journal: BMC Cancer. 2010 Jun 18;10:302.
Title: Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.
Author: Xu, Ling|Hausmann, Martin|Dietmaier, Wolfgang|Kellermeier, Silvia|Pesch, Theresa|Stieber-Gunckel, Manuela|Lippert, Elisabeth|Klebl, Frank|Rogler, Gerhard
PMID: 20565817
Journal: PLoS One. 2013 May 21;8(5):e64186.
Title: EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.
Author: Hoffmann, Andreas-Claudius|Goekkurt, Eray|Danenberg, Peter V|Lehmann, Sylvia|Ehninger, Gerhard|Aust, Daniela E|Stoehlmacher-Williams, Jan
PMID: 23704979
Journal: Jpn J Clin Oncol. 2014 Jun;44(6):570-8.
Title: Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
Author: Takahashi, Hiroyuki|Ojima, Hidenori|Shimizu, Hiroko|Furuse, Junji|Furukawa, Hiroyuki|Shibata, Tatsuhiro
PMID: 24755544
Journal: Oncotarget. 2016 Mar 29;7(13):17220-9.
Title: Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma.
Author: Peng, Hong|Zhang, Qiuyang|Li, Jiali|Zhang, Ning|Hua, Yunpeng|Xu, Lixia|Deng, Yubin|Lai, Jiaming|Peng, Zhenwei|Peng, Baogang|Chen, Minhu|Peng, Sui|Kuang, Ming
PMID: 26967384
Journal: Am J Cancer Res. 2018 Jan 1;8(1):2-15. eCollection 2018.
Title: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.
Author: Papadopoulou, Kyriaki|Murray, Samuel|Manousou, Kyriaki|Tikas, Ioannis|Dervenis, Christos|Sgouros, Joseph|Rontogianni, Dimitra|Lakis, Sotirios|Bobos, Mattheos|Poulios, Christos|Pervana, Stavroula|Lazaridis, Georgios|Fountzilas, George|Kotoula, Vassiliki
PMID: 29416916
Journal: Br J Cancer. 2018 Jul;119(1):27-35.
Title: Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
Author: Backen, Alison C|Lopes, Andre|Wasan, Harpreet|Palmer, Daniel H|Duggan, Marian|Cunningham, David|Anthoney, Alan|Corrie, Pippa G|Madhusudan, Srinivasan|Maraveyas, Anthony|Ross, Paul J|Waters, Justin S|Steward, William P|Rees, Charlotte|McNamara, Mairead G|B
PMID: 29925934
Journal: Pathol Res Pract. 2018 Aug;214(8):1136-1141.
Title: Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Author: Bosmuller, Hans|Pfefferle, Vanessa|Bittar, Zeid|Scheble, Veit|Horger, Marius|Sipos, Bence|Fend, Falko
PMID: 29935812